Surgical management of perianal fistula using an ovine forestomach matrix implant
Authors:
Open Access
- 3 May 2023
- journal article
- research article
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 27 (9) , 769-774
Abstract
Purpose: Invasive surgical management of cryptoglandular perianal fistulas (PF) is challenging because of high recurrence rates and the potential for injury to the sphincter complex. In the present technical note, we introduce a minimally invasive treatment for PF using a perianal fistula implant (PAFI) comprising ovine forestomach matrix (OFM). Methods: This retrospective observational case series highlights 14 patients who had undergone a PAFI procedure at a single center between 2020 and 2023. During the procedure, previously deployed setons were removed and tracts were de-epithelialized with curettage. OFM was rehydrated, rolled, passed through the debrided tract, and secured in place at both openings with absorbable suture. Primary outcome was fistula healing at 8 weeks, and secondary outcomes included recurrence or postoperative adverse events. Results: Fourteen patients underwent PAFI using OFM with a mean follow-up period of 37.6 ± 20.1 weeks. In follow-up, 64% (n = 9/14) had complete healing at 8 weeks and all remained healed, except one at last follow-up visit. Two patients underwent a second PAFI procedure and were healed with no recurrence at the last follow-up visit. Of all patients that healed during the study period (n = 11), the median time to healing was 3.6 (IQR 2.9–6.0) weeks. No postprocedural infections nor adverse events were noted. Conclusions: The minimally invasive OFM-based PAFI technique for PF treatment was demonstrated to be a safe and feasible option for patients with trans-sphincteric PF of cryptoglandular origin.Keywords
This publication has 10 references indexed in Scilit:
- Surgical reconstruction of pilonidal sinus disease with concomitant extracellular matrix graft placement: a case seriesJournal of Wound Care, 2021
- Fistula Laser Closure (FiLaC™) for fistula-in-ano—yet another technique with 50% healing rates?International Journal of Colorectal Disease, 2021
- Extracellular matrix graft for reconstruction over exposed structures: a pilot case seriesJournal of Wound Care, 2020
- A novel chemotactic factor derived from the extracellular matrix protein decorin recruits mesenchymal stromal cells in vitro and in vivoPLOS ONE, 2020
- Randomized clinical trial comparing collagen plug and advancement flap for trans-sphincteric anal fistulaBritish Journal of Surgery, 2017
- Mesenchymal Stem Cell Injections for the Treatment of Perianal Crohn’s Disease: What We Have Accomplished and What We Still Need to DoJournal of Crohn's and Colitis, 2017
- Short-Term Results of Treating Primary and Recurrent Anal Fistulas with a Novel Extracellular Matrix Derived from Porcine Urinary BladderThe American Surgeon™, 2015
- Ovine forestomach matrix biomaterial is a broad spectrum inhibitor of matrix metalloproteinases and neutrophil elastaseInternational Wound Journal, 2012
- Randomized clinical trial of anal fistula plugversusendorectal advancement flap for the treatment of high cryptoglandular fistulain anoBritish Journal of Surgery, 2009
- Collagen Fistula Plug for the Treatment of Anal FistulasDiseases of the Colon & Rectum, 2008